Age, anti-müllerian hormone, antral follicles count to predict amenorrhea or oligomenorrhea after chemotherapy with cyclophosphamide

BACKGROUND: A cohort study was performed to identify ovarian reserve markers (ORM) that predicts amenorrhea or oligomenorrhea 6 months after cyclophosphamide CTX in women with breast cancer. METHODS: 52 eumenorrheic patients with breast cancer were enrolled. FSH, anti-Müllerian hormone (AMH), antral...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Avila, Ângela Marcon, Biolchi, Vanderlei, Capp, Edison, Corleta, Helena von Eye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678664/
https://www.ncbi.nlm.nih.gov/pubmed/26667243
http://dx.doi.org/10.1186/s13048-015-0209-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678664/
https://www.ncbi.nlm.nih.gov/pubmed/26667243
http://dx.doi.org/10.1186/s13048-015-0209-4

Ejemplares similares